Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Tranexamic acid manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

3 products found

tranexamic acid

Injection 100 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #35915

Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 7 days

tranexamic acid

Tablets 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311
This pharmaceutical company specializes in developing and supplying drug products and substances to global markets. Their focus is on innovation and quality, offering both prescription and over-the-counter products. The company boasts strong GMP certifications, ensuring adherence to international standards. Their portfolio likely includes solid dosage forms and may extend to injectables or liquids. While specific therapy areas are not mentioned, the focus on advanced markets suggests specialization in areas like oncology, cardiology, or neurology. With a proven track record of supplying high-quality pharmaceuticals, they likely hold multiple product patents. The company's decades-long presence in the industry, particularly in the European Union and North America, underscores their commitment to global healthcare solutions.

Manufacturer usually replies in 13 days

tranexamic acid

Cream 10 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19152
This company specializes in advanced skincare solutions for a variety of skin types, encompassing both cosmetic and clinical dermatology needs. Their product portfolio includes innovative medicines and cosmetics, with a focus on high-tech, natural ingredients and allopathic actives. They emphasize research and development, collaborating with medical professionals to deliver effective and visible results. The company adheres to strict quality standards and regulatory compliance, ensuring patient safety and consumer satisfaction. While their primary focus is on the EU and North America regions, their commitment to continuous improvement positions them as a leader in the global dermatology market.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.